Canada's cannabis products routinely mislabelled, a Nova Scotia study finds

Global News in Canada shows that since Canada legalized cannabis in 2018, sales have skyrocketed to an industry now worth $4 billion a year in the country. 

But Nova Scotia scientists have made troubling discovery over the products - cannabis strains are being regularly mixed up and mislabelled on the shelves. 

The Cannabis Council of Canada, which represents more than 700 licensed growers in the country, suggests it's a lingering effect from the illegal cannabis market. 

Ross Lord looks at how exactly it's messing up the marketing over scientific facts - and why it could be dangerous.

Canada: Cannabis retailers stung by big bank rejection

CBC News in Canada shows that nearly 3 years after Canada legalized cannabis, many retailers in B.C. claim they still struggle to find access to basic financial services from banks. Industry experts say international pressure and decades of stigma plague the fledgling industry.

Aphria stock price is impressive compared to similar pot companies

Aphria Marijuana Stock is an interesting investment. Canadian cannabis sales are continuing to increase month after month in these days of the global coronavirus Covid-19 pandemic.

The latest interesting data from Statistics Canada show that in June, retail sales topped 201 million Canadian dollars and were up 8% from May's total sales. The Canadian government legalized marijuana in October 2018. The legal market sales have certainly been increasing. The Canadian pot market has opportunities.

Companies like Aphria (NASDAQ:APHA) and Aurora Cannabis (NYSE:ACB) seem to be ready to get more share of the rapidly expanding marketplace. Aphria sure wants to get more Aphria market share.

Aphria is coming off a tough quarter, but it is hopeful. Ontario-based Aphria is usually more consistent than Aurora. When Aphria released its 4th-quarter results on July 29 for the period ending in May, it reported a loss of CA$98.8 million. Impairment charges of CA$64 million weighed down its results, as did non-operating losses of CA$23 million. Despite a disappointing bottom line, Aphria still achieved positive adjusted-EBITDA for the 5th consecutive period, totaling CA$8.6 million in Q4.

Aphria has the strength of its diversified distribution structure. In its most recent fiscal year, CA$369.2 million of its CA$543.3 million in net revenue came from distribution revenue.

Aphria Inc. is a Canadian cannabis company. It is listed on the TSE (Toronto Stock Exchange) and the NYSE (New York Stock Exchange). It has a market capitalization of about $3 billion. The company was founded back in 2014.

In 2017, Aphria announced an exciting USA expansion strategy. Investors had concerns that Aphria might be delisted from the Toronto Stock Exchange or face other difficult sanctions. This is because of the uncertain legal status of cannabis in the USA (different in different states).

Keep in mind, the price-earnings ratio, also known as P/E ratio is the ratio of a company's share price to the company's earnings per share. The ratio is used for valuing companies. You could find out whether they are overvalued or undervalued.

Canada Pot Stocks to watch in 2020

There is something that is hurting Canada’s legal cannabis industry. It is the lack of stores. For example, Weed Me’s growing facility in Pickering, Ont. is crammed with cannabis plants. It's hard even for people to walk between the plants. Right now, the only way to get those products is to get a script from a doctor and sign up as a patient. Then the company can sell directly to them. Otherwise, they can get the product only on the other side of the nation like Vancouver.

After legalization, here are some interesting pot stocks to watch in 2020. A lot of stocks have declined, but some could make a comeback. The Canada company pot revenues are expected to increase. Canada pot growers stock market is fascinating.

Canopy Growth Corp Stock Will Probably Continue to Decline

Aurora Cannabis Inc. Stock Continues to Face Short-Term Challenges

Aphria Inc. Stock seems to be sinking

Cronos Group Inc. Stock could fall even more

Hexo Corp Stock rebounds from low price

CannTrust Holdings Inc. Stock descends a lot in 2019

Namaste Technologies Inc. Stock could make a comeback

OrganiGram Holdings Inc. Stock could be headed downhill

Emerald Health Therapeutics Inc. Stock tumbles in 2019

Supreme Cannabis Company Inc. Stock is at lows

Above: some people have jokingly created the "Canada Marijuana Flag." Looks interesting.

Above: Close-ups of pot

Above: Marijuana Greenhouse

Above: Cannabis Farm

Marijuana in Canada

Now that marijuana is legal in Canada, sales have increased. Take a look at these interesting statistics charts. Cannabis was banned in Canada from 1923. Now Cannabis in Canada is legal for both recreational and medicinal purposes. Medicinal use was legalized on 30 July 2001. The federal Cannabis Act came into effect on 17 October 2018 and made Canada the second country in the world, after Uruguay, to formally legalize it. Canada is the first G7 and G20 nation to do so.

Here is a list of 10 Canadian Marijuana Stocks that would be good for your Portfolio:

1. Canopy Growth Corp. - Market Cap: $12.4 billion
2. Aurora Cannabis - Market Cap: $10.61 billion
3. Aphria Inc. - Market Cap: $3.64 billion
4. The Cronos Group - Market Cap: $1.37 billion
5. The Hexo Corperation - Market Cap: $1.266 billion
6. CannTrust Holdings Inc. - Market Cap: $1.10 billion
7. Namaste Technologies Inc. - Market Cap: $547.42
8. OrganiGram Holdings - Market Cap: $759.73 million
9. Emerald Health Therapeutics - Market Cap: $513.91 million
10. The Supreme Cannabis Company Inc. - Market Cap: $445.50 million